BIOCON : EMA RECOMMENDS PERTUZUMAB BIOSIMILAR
21-Sept-2026 08:28:05BIOCONGeneral newsBIOCON : EMA RECOMMENDS PERTUZUMAB BIOSIMILARBiocon LimitedOpen attachment← Back to feed